EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Thyroid Malignancies With Thymic Differentiation: Outcomes of Rare SETTLE and CASTLE Tumors

Iulia Tapescu iD, Abigail Kohler, Neel R Sangal, Jason A Brant iD, Robert M Brody iD, Timothy Chao, Ryan M Carey iD

Head & Neck · 2025

DOI: 10.1002/hed.27969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Head & Neck, 2025. Verfasst von Iulia Tapescu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Thyroid Cancer, Papillary, Neoplasms, Glandular and Epithelial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Spindle epithelial tumors with thymus‐like differentiation (SETTLE) and carcinomas showing thymus‐like differentiation (CASTLE) are rare intrathyroid tumors.

Methods

This retrospective cohort study included patients diagnosed with SETTLE, CASTLE, and papillary thyroid carcinoma (PTC) from 2004 to 2020 within the National Cancer Database (NCDB). Demographic, tumor, and treatment characteristics were compared. Overall survival (OS) was analyzed using the Kaplan–Meier method and Cox regression models.

Results

This study identified 19 patients with CASTLE, 11 with SETTLE, and 483 474 with PTC. CASTLE and SETTLE patients had larger tumors, lymphovascular invasion, and positive surgical margins. They were rarely treated with radioactive iodine treatment but frequently received external beam radiation and chemotherapy. Five‐year OS was significantly lower for CASTLE and SETTLE compared to PTC. SETTLE was associated with an increased risk of death.

Conclusion

SETTLE and CASTLE are rare intrathyroid tumors with worse survival compared to PTC, often managed with radiation, chemotherapy, and surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsThyroid Cancer, PapillaryNeoplasms, Glandular and EpithelialHumansMaleRetrospective StudiesFemaleMiddle AgedAdultAgedThyroidectomyDatabases, FactualKaplan-Meier Estimate

Stichwörter der Autor:innen

CASTLESETTLEpapillary thyroid carcinomathymus‐like tumors

Autor:innen und Institutionen

  • Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Otorhinolaryngology-Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Department of Otolaryngology-Head and Neck Surgery, University of Wisconsin, Madison, Wisconsin, USA.
  • Department of Otolaryngology-Head and Neck Surgery, Corporal Michael J. Crescenz Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA.
  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Iulia Tapescu, Jason A Brant, Robert M Brody, Ryan M Carey

Zitieren

APA

Tapescu, I., Kohler, A., Sangal, N. R., Brant, J. A., Brody, R. M., Chao, T., & Carey, R. M. (2025). Thyroid Malignancies With Thymic Differentiation: Outcomes of Rare SETTLE and CASTLE Tumors. Head & Neck. https://doi.org/10.1002/hed.27969

Vancouver

Tapescu I, Kohler A, Sangal NR, Brant JA, Brody RM, Chao T, et al. Thyroid Malignancies With Thymic Differentiation: Outcomes of Rare SETTLE and CASTLE Tumors. Head & Neck. 2025. doi:10.1002/hed.27969

BibTeX
@article{Tapescu2025,
  author = {Tapescu, Iulia and Kohler, Abigail and Sangal, Neel R and Brant, Jason A and Brody, Robert M and Chao, Timothy and Carey, Ryan M},
  title = {Thyroid Malignancies With Thymic Differentiation: Outcomes of Rare SETTLE and CASTLE Tumors},
  journal = {Head & Neck},
  year = {2025},
  doi = {10.1002/hed.27969}
}
Kostenlos starten →